Table 2 Univariate and multivariate Cox regression analysis for OS of HCC patients baseline

GGT, U/L (≤60/>60)

23(39.0%)/36(61.0%)

181(60.1%)/120(39.9%)

0.003

2.192(1.297-3.702)

–

–

DB, umol/l (≤8/>8)

41(69.5%)/18(30.5%)

256(85.0%)/45(15.0%)

0.008

2.107(1.210-3.668)

–

–

AFP,ng/mL

≤20

13(22.0%)

154(51.2%)

–

–

–

20-400

15(25.5%)

81(26.9%)

0.037

2.204(1.048-4.633)

0.077

1.977(0.928-4.21)

>400

31(52.5%)

66(21.9%)

<0.001

3.991(2.088-7.629)

0.001

3.093(1.589-6.023)

PNI

45.50(26.6,65.8)

49.40(26.50,73.30)

0.001

0.940(0.906-0.974)

0.014

0.953(0.917-0.99)

NLR

1.93(0.52,73.33)

2.06(0.40,25.75)

<0.001

1.072(1.037-1.107)

0.001

1.061(1.026-1.098)

SIRI

0.92(0.21,75.43)

0.85(0.22,21.45)

<0.001

1.040(1.017-1.063)

–

–

MVI(yes/no)

45(76.3%)/14(23.7%)

135(44.9%)/166(55.1%)

<0.001

3.348(1.837-6.102)

0.010

2.294(1.225-4.297)

Tumour diameter,cm

6.39±3.33

4.71±2.95

<0.001

1.129(1.064-1.198)

–

–

PVTT(yes/no)

12(20.3%)/47(79.7%)

18(6.0%)/283(94.0%)

<0.001

3.783(1.999-7.158)

0.002

2.800(1.459-5.374)